Rockwall, TX, United States of America

Louis M Dyll



Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1989-1992

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Louis M Dyll: Innovator in Rapid Diagnostic Methods

Introduction

Louis M Dyll is a notable inventor based in Rockwall, TX (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of retroviral antibodies. With a total of 2 patents, Dyll's work has had a profound impact on the way certain diseases are diagnosed.

Latest Patents

Dyll's latest patents include innovative methods for the rapid and sensitive detection of various antibodies. His notable inventions are:

1. Method for rapid and sensitive detection of IgM retroviral antibodies.

2. Method for rapid and sensitive detection of HIV-1 antibodies.

3. A rapid and sensitive assay method for the detection of antibodies to Human T-Cell Leukemia Virus-III (HIV-I), the AIDS virus, and diagnostic test kits for carrying out the method.

These methods, referred to as Quick Western Blot II or Rapid Western Blot, involve incubating electrophoretically resolved HIV-I antigen in the presence of milk proteins, enhancing the detection process.

Career Highlights

Throughout his career, Dyll has worked with various organizations that focus on biotechnological advancements. Notable companies include 501 Bio-Research Laboratories, Inc. and Verigen, Inc. His work in these companies has contributed to the development of effective diagnostic tools.

Collaborations

Dyll has collaborated with several professionals in his field, including his coworker Kurt B Osther. These collaborations have furthered the research and development of innovative diagnostic methods.

Conclusion

Louis M Dyll's contributions to the field of medical diagnostics through his patents and collaborations have significantly advanced the detection of retroviral antibodies. His work continues to influence the medical community and improve diagnostic practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…